ADRIENNE BELLINO AILINGER: Open Payments
NPI 1669299202 · TELFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 23 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $213 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $109 |
| Novo Nordisk Inc | 4 | $104 |
| ABBVIE INC. | 5 | $96 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: AREXVY, VRAYLAR, SHINGRIX, ZEPBOUND, BREZTRI, GEMTESA, Wegovy, XIFAXAN.
Industry payments across PA — which companies pay providers there.
